Here's Why Agios Stock Plummeted More Than 20% on Monday

Zacks Dec 10 10:00 ET

Scotiabank Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $75

Moomoo NewsDec 10 08:31 ET · Ratings

RBC Raises Price Target on Agios Pharmaceuticals to $57 From $55, Keeps Outperform Rating

MT NewswiresDec 10 07:12 ET · Ratings

Small U.S. Stocks Decrease; Agios Pharmaceuticals Posts Biggest Loss

Dow JonesDec 9 16:20 ET

Agios Pharmaceuticals Down Nearly 22%, on Pace for Record Percent Decrease -- Data Talk

Dow JonesDec 9 12:46 ET

Agios Pharmaceuticals Is Maintained at Sector Outperform by Scotiabank

Dow JonesDec 9 10:49 ET · Ratings